NUTEX — Nutex Befektetesi Nyrt Income Statement
0.000.00%
- HUF3.15bn
- -HUF1.91bn
- HUF0.45m
- 49
- 28
- 59
- 38
Annual income statement for Nutex Befektetesi Nyrt, fiscal year end - December 31st, HUF millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.75 | 0.45 | 0.45 | 0.45 | 0.45 |
Cost of Revenue | |||||
Gross Profit | 0.75 | — | — | — | 0.45 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.2 | 18 | 13.6 | 16.4 | 21.5 |
Operating Profit | -9.49 | -17.6 | -13.1 | -16 | -21.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.72 | 27.3 | 13.3 | 139 | 178 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.01 | 26.1 | 12.7 | 134 | 171 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.01 | 26.1 | 12.7 | 134 | 171 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.01 | 26.1 | 12.7 | 134 | 171 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.216 | 0.365 | 0.086 | 0.902 | 1.16 |
Dividends per Share |